S&P Futures
3,943.25 -3.75 (-0.10%) Dow Futures
32,046.00 -25.00 (-0.08%) Nasdaq Futures
12,630.25 -14.50 (-0.11%) Russell 2000 Futures
1,744.00 +5.60 (+0.32%) Crude Oil
65.94 -0.80 (-1.20%) Gold
1,987.10 +13.60 (+0.69%)
Oppenheimer Holdings Inc. (OPY)
After hours:
Chart Events
Performance Outlook
| Previous Close | 40.64 |
| Open | 40.24 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1100 |
| Day's Range | 39.15 - 40.24 |
| 52 Week Range | 28.41 - 49.32 |
| Volume | |
| Avg. Volume | 94,252 |
| Market Cap | 453.845M |
| Beta (5Y Monthly) | 1.16 |
| PE Ratio (TTM) | 15.25 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.60 (1.53%) |
| Ex-Dividend Date | Feb 09, 2023 |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for OPY
Related Research
- Oppenheimer Holdings, Inc.Analyst Report: JPMorgan Chase & Co.JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.RatingFair ValueEconomic Moat3 days agoMorningstar
- PR Newswire
OPPENHEIMER LEADS $55 MILLION SERIES C FOR PERSPECTUM
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) —announced today the completion of a Series C funding round for Perspectum, a United Kingdom-based medical imaging and diagnostic technology provider.
- PR Newswire
Oppenheimer & Co. Inc. Announces 33rd Annual Healthcare Conference
Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – today announced its 33rd Annual Healthcare Conference will be held March 13 – 15. The virtual event will include a broad spectrum of over 225 public and private healthcare companies across all major sectors of the industry, including bio and specialty pharmaceuticals, biotechnology, medical devices, life science tools and diagnostics, and healthcare providers
- PR Newswire
Oppenheimer Announces Expansion of Investment Grade Fixed Income Sales Team
Oppenheimer & Co. Inc. ("Oppenheimer") — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today the continued expansion of its Investment Grade desk with the additions of Perren Thomas, Dennis Megley and Mike Henneberry. Each will serve as Managing Directors on the Investment Grade Sales team in New York and report to Katie Lucas, Managing Director, and Head of Investment Grade Sales.
